Pluvicto Real-world Investigation in Survival in Metastatic CRPC

Clinical trial NCT07697989 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07697989
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Prostatic Neoplasms, Castration-Resistant Neoplasm Metastasis

Start date: 2026-10-15
Primary completion: 2027-01-31
Enrollment: 1085

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.